Pathwork Diagnostics presents clinical utility study results
Pathwork Diagnostics, a privately held molecular diagnostics company focused on oncology, has presented results from a decision impact…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Jan 11
Pathwork Diagnostics, a privately held molecular diagnostics company focused on oncology, has presented results from a decision impact…
25 Jan 11
Actient Pharmaceuticals has acquired Timm Medical Technologies, a provider in products and services for the diagnosis and treatment…
25 Jan 11
The University of Michigan Cardiovascular Center and the University of Pittsburgh will conduct a study to evaluate the…
25 Jan 11
HemCon Medical Technologies, a developer, manufacturer and marketer of technologies to control bleeding and infection resulting from trauma…
25 Jan 11
Merge Healthcare, a health IT solutions provider, has deployed an imaging distribution solution iConnect Access for the physicians…
25 Jan 11
A test for DNA methylation can aid in earlier, more precise diagnosis of melanoma, according to a new…
25 Jan 11
Health Market Science (HMS), a source for healthcare provider data and solutions, and business partner Alanda, a developer…
25 Jan 11
Small Bone Innovations, Inc (SBi), an orthopedics company, has received the US Food and Drug Administration (FDA) 510(k)…
25 Jan 11
Novartis has entered into a definitive agreement for the acquisition of Genoptix, a provider of personalized diagnostic services…
25 Jan 11
Boston Scientific has completed patient enrollment in the Evolve clinical trial, designed to assess the safety and performance…